CHEPLAPHARM Arzneimittel GmbH
PolandAll drugs from this manufacturer
-
The medicine is intended for the treatment of diseases caused by cytomegalovirus (CMV) in adults and adolescents (over 12 years of age) with a weakened immune system. It is also used to prevent infections with this virus following organ transplantation or during chemotherapy.
Dosage form: powder for preparation of concentrate for infusion solution
ATC: J05AB06
-
The medicine is intended for the treatment of diseases caused by cytomegalovirus (CMV) in immunocompromised adults and adolescents (over 12 years of age). It is also used to prevent infections with this virus following organ transplantation or during chemotherapy in adults and children.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage ganciclovir 500 mg ATC: J05AB06
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis or frequent urination.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as sudden urgency to urinate, urinary incontinence, or frequent urination. It may also be used in children (over 5 years of age) for the treatment of nocturnal enuresis and voiding problems resulting from a neurogenic bladder.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis or frequent urination.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis, frequent urination, or loss of bladder control.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis or frequent urination.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis or frequent urination.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis (bedwetting) or frequent urination.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to relieve symptoms of bladder instability, such as urgency, urinary incontinence, or difficulty urinating. It may also be used in children (over 5 years of age) in cases of nocturnal enuresis or frequent urination.
Dosage form: tablets
Active substance Dosage oxybutynin hydrochloride 5 mg ATC: G04BD04
-
The medicine is used to treat patients with severe, life-threatening fungal infections.
Dosage form: solution for infusion, powder for preparation of
Active substance Dosage amphotericin b 50 mg ATC: J02AA01
-
The medicine is intended for the treatment of severe orthostatic hypotension, which is a sudden drop in blood pressure upon standing that causes dizziness or fainting. It is used when causal treatment of these disorders is not possible.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
It is used to treat severe orthostatic hypotension, which is a sudden drop in blood pressure upon standing that can cause dizziness or fainting. The medicine raises blood pressure by constricting blood vessels.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
The medicine is used to treat severe orthostatic hypotension (a sudden drop in blood pressure upon standing, which causes dizziness or fainting) caused by neurological disorders.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
The medicine is intended for the treatment of severe orthostatic hypotension (a sudden drop in blood pressure upon standing, which causes dizziness or fainting) caused by neurological disorders.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
The medicine is intended for the treatment of severe orthostatic hypotension (a sudden drop in blood pressure upon standing, which causes dizziness or fainting) caused by neurological disorders.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
The medicine is used to treat severe orthostatic hypotension (a sudden drop in blood pressure upon standing, which causes dizziness or fainting) caused by nervous system disorders.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
The medicine is used to treat severe orthostatic hypotension (a sudden drop in blood pressure upon standing), which manifests as dizziness or fainting and is caused by nervous system disorders.
Dosage form: tablets
Active substance Dosage midodrine hydrochloride 2.5 mg ATC: C01CA17
-
The medicine is used to treat high blood pressure (hypertension) and chronic (long-term) heart failure.
Dosage form: tablets, film-coated
ATC: C09AA08
-
The medicine is used to treat high blood pressure (hypertension) and chronic (long-term) heart failure.
Dosage form: tablets, film-coated
Active substance Dosage cilazapril 1 mg ATC: C09AA08
-
The medicine is used in the treatment of high blood pressure (arterial hypertension) and chronic (long-term) heart failure.
Dosage form: tablets, film-coated
Active substance Dosage cilazapril 5 mg ATC: C09AA08
-
The medicine is used to treat high blood pressure (hypertension) and chronic (long-term) heart failure.
Dosage form: tablets, film-coated
Active substance Dosage cilazapril 2.5 mg ATC: C09AA08
-
This medicine is used to treat high blood pressure. It contains two substances that work together to lower blood pressure.
Dosage form: tablets, film-coated
Active substance Dosage cilazapril 5.22 mg hydrochlorothiazide 12.5 mg ATC: C09BA08
-
It is used in the treatment of generalized anxiety disorders, anxiety states occurring in chronic neurological diseases, post-traumatic stress disorders, adjustment disorders, and in autonomic dysfunctions manifesting, among other things, as skin, gastrointestinal, circulatory, or genitourinary problems.
Dosage form: tablets
Active substance Dosage bromazepam 6 mg ATC: N05BA08
-
The medicinal product is intended for the treatment of, among others, generalized anxiety disorders, anxiety states occurring in chronic diseases of the nervous system, post-traumatic stress disorders, and adjustment disorders. It is also used in autonomic dysfunctions manifesting, among others, as skin, gastrointestinal, circulatory, or urogenital problems.
Dosage form: tablets
Active substance Dosage bromazepam 3 mg ATC: N05BA08
-
The medicinal product is intended for the treatment of, among others, generalized anxiety disorders, post-traumatic stress disorders, adjustment disorders, and anxiety states occurring in the course of chronic neurological diseases. It is also used in autonomic dysfunctions manifesting, among others, in the gastrointestinal, circulatory, or skin systems.
Dosage form: tablets
Active substance Dosage bromazepam 6 mg ATC: N05BA08
-
It is used in the treatment of generalized anxiety disorders, anxiety states occurring in the course of nervous system diseases, post-traumatic stress disorders, adjustment disorders, and autonomic dysfunctions manifesting, among other things, as skin, gastrointestinal, circulatory, or urogenital problems.
Dosage form: tablets
Active substance Dosage bromazepam 6 mg ATC: N05BA08
-
It is used in the treatment of generalized anxiety disorders, anxiety states occurring in diseases of the nervous system, post-traumatic stress disorders, adjustment disorders, and autonomic dysfunctions manifesting, among other things, as skin, gastrointestinal, circulatory, or genitourinary problems.
Dosage form: tablets
Active substance Dosage bromazepam 3 mg ATC: N05BA08
-
It is used in the treatment of generalized anxiety disorders, anxiety states occurring in chronic diseases of the nervous system, post-traumatic stress disorders, adjustment disorders, and autonomic dysfunctions manifesting, among other things, as skin, gastrointestinal, circulatory, or genitourinary problems.
Dosage form: tablets
Active substance Dosage bromazepam 3 mg ATC: N05BA08
-
The medicinal product is used in the treatment of generalized anxiety disorders, anxiety states occurring in chronic neurological diseases, post-traumatic stress disorders, adjustment disorders, and autonomic dysfunctions manifesting, among others, as skin, gastrointestinal, circulatory, or urogenital problems.
Dosage form: tablets
Active substance Dosage bromazepam 3 mg ATC: N05BA08
-
The medicinal product is intended for the treatment of, among others, generalized anxiety disorders, post-traumatic stress disorders, adjustment disorders, and anxiety states occurring in the course of chronic neurological diseases. It is also used in autonomic dysfunctions manifesting, among others, in the gastrointestinal, circulatory, or skin systems.
Dosage form: tablets
Active substance Dosage bromazepam 3 mg ATC: N05BA08
-
The medicinal product is intended for the treatment of, among others, generalized anxiety disorders, adjustment disorders, post-traumatic stress disorders, and anxiety states occurring in the course of chronic neurological diseases. It is also used in autonomic dysfunctions manifesting, among others, in the gastrointestinal, circulatory, or skin systems.
Dosage form: tablets
Active substance Dosage bromazepam 6 mg ATC: N05BA08
-
It is used to treat skin inflammation (not caused by microorganisms), which is often accompanied by itching. It also helps in maintaining the treatment of inflammatory skin diseases if stronger medications were previously used.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used to relieve skin inflammation (not caused by microorganisms) and the associated itching. It is intended for the treatment of dry and dry-exudative skin lesions.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used to relieve skin inflammation (not caused by microorganisms) and the associated itching. It also helps in continuing the treatment of inflammatory skin diseases if the previous use of stronger medicines yielded good results.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used to treat skin inflammation (not caused by microorganisms), which may also manifest as itching. It helps to relieve the symptoms of inflammatory skin diseases.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used to relieve the symptoms of skin inflammation (not caused by microorganisms), which is often accompanied by itching. It is intended for the treatment of inflammation when weaker medicines do not provide results, or to maintain the treatment of skin diseases that previously responded well to stronger preparations.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used to relieve skin inflammation (not caused by microorganisms) and the associated itching. It also helps in continuing the treatment of inflammatory skin diseases if the previous use of stronger medicines has yielded good results.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used to relieve skin inflammation (not caused by microorganisms) and the associated itching. It is intended for the treatment of dry and dry-weeping skin lesions.
Dosage form: cream
Active substance Dosage hydrocortisone butyrate 1 mg/g ATC: D07AB02
-
The medicine is used in the treatment of arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used in the treatment of arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used in the treatment of arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used in the treatment of arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used in the treatment of arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used to treat arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used in the treatment of arterial hypertension and ischemic heart disease.
Dosage form: tablets, film-coated
Active substance Dosage betaxolol hydrochloride 20 mg ATC: C07AB05
-
The medicine is used in the treatment of gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive gastric acid secretion.
Dosage form: capsules, hard, intestinal
Active substance Dosage omeprazole 20 mg ATC: A02BC01
-
The medicine is used to reduce the amount of acid secreted in the stomach. It helps in the treatment of gastroesophageal reflux disease, gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive acid secretion in Zollinger-Ellison syndrome.
Dosage form: capsules, hard, intestinal
Active substance Dosage omeprazole 20 mg ATC: A02BC01
-
The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive acid secretion in the pancreas.
Dosage form: capsules, hard, intestinal
Active substance Dosage omeprazole 20 mg ATC: A02BC01
-
It is used in the treatment of bladder emptying disorders (resulting from bladder muscle flaccidity in neurological diseases), constipation caused by intestinal muscle flaccidity, and as support in myasthenia gravis (pathological muscle weakness).
Dosage form: tablets
Active substance Dosage distigmine bromide 5 mg ATC: N07AA03